Hercules Capital, Inc. (HTGC): Price and Financial Metrics

Hercules Capital, Inc. (HTGC): $19.41

0.00 (0.00%)

POWR Rating

Component Grades

Momentum

C

Stability

C

Sentiment

Quality

C

Add HTGC to Watchlist
Sign Up

Industry: Private Equity

Industry

D

Ranked

#16 of 34

in industry

HTGC Price/Volume Stats

Current price $19.41 52-week high $20.01
Prev. close $19.41 52-week low $14.05
Day low $19.30 Volume 764,200
Day high $19.56 Avg. volume 936,530
50-day MA $18.81 Dividend yield 8.24%
200-day MA $17.15 Market Cap 3.15B

HTGC Stock Price Chart Interactive Chart >


Hercules Capital, Inc. (HTGC) Company Bio


Hercules Technology Growth Capital, Inc. is a business development company specializing in providing venture debt, debt, senior secured loans, and growth capital to privately held venture capital-backed companies at all stages of development including select publicly listed companies and select special opportunity lower middle market companies that require additional capital to fund acquisitions, recapitalizations and re-financings and established-stage companies. The company was founded in 2003 and is based in Palo Alto, California.


HTGC Latest News Stream


Event/Time News Detail
Loading, please wait...

HTGC Latest Social Stream


Loading social stream, please wait...

View Full HTGC Social Stream

Latest HTGC News From Around the Web

Below are the latest news stories about HERCULES CAPITAL INC that investors may wish to consider to help them evaluate HTGC as an investment opportunity.

Hercules Capital (HTGC) Outperforms Broader Market: What You Need to Know

In the latest trading session, Hercules Capital (HTGC) closed at $16.41, marking a +0.98% move from the previous day.

Yahoo | December 22, 2023

enGene Announces Expanded $50 Million Debt Facility with Hercules Capital

enGene Holdings Inc. ("enGene," Nasdaq: ENGN), a clinical-stage genetic medicines company whose lead EG-70 program is in a pivotal study for BCG-unresponsive non-muscle invasive bladder cancer (NMIBC), announced today that it has entered into an amended USD $50 million loan agreement (the "Loan Agreement") with Hercules Capital, Inc. (NYSE: HTGC) ("Hercules"). Under the Loan Agreement, which has a term of four years, $22.5 million has been advanced to enGene under a non-revolving term loan and,

Yahoo | December 22, 2023

Investors in Hercules Capital (NYSE:HTGC) have seen splendid returns of 155% over the past five years

When you buy and hold a stock for the long term, you definitely want it to provide a positive return. Furthermore...

Yahoo | December 17, 2023

This Dividend Stock Has Returned 157% Over the Past 10 Years. You Can Buy It Today for Just $15

Hercules Technology Growth Capital makes high-yield loans to energy, life sciences, and technology businesses.

Yahoo | December 15, 2023

Phathom Pharmaceuticals Announces Expansion of Existing Loan and Security Agreement with Hercules Capital

Amendment provides more favorable terms including a 14-month extension of the interest-only period and maturity date until December 2027Up to an additional $100 million in non-dilutive capital available subject to the achievement of certain revenue milestonesCash runway now expected through the end of 2026 FLORHAM PARK, N.J., Dec. 14, 2023 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for g

Yahoo | December 14, 2023

Read More 'HTGC' Stories Here

HTGC Price Returns

1-mo 3.48%
3-mo 10.13%
6-mo 32.54%
1-year 46.60%
3-year 61.90%
5-year 165.52%
YTD 22.45%
2023 42.91%
2022 -9.51%
2021 25.99%
2020 15.13%
2019 39.86%

HTGC Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full HTGC Dividend History

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!